8 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| The Scripps Research Institute | 5 |
| The Scripps Research Institute | 2 |
| Shangpharma Innovation Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18578875 | SMALL MOLECULES INHIBITORS OF CYCLIC GMP-AMP SYNTHASE (cGAS) | Shangpharma Innovation Inc. | KIM, SEONG JONG | 1621 | Non-Final OA | Jan 12, 2024 |
| 18548635 | HETEROBIFUNCTIONAL COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION AND METHODS FOR THEIR USE | The Scripps Research Institute | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Sep 01, 2023 |
| 18350798 | SMALL MOLECULES FOR REPROGRAMING ANTI-TUMOR IMMUNITY OF T CELLS | The Scripps Research Institute | BORGEEST, CHRISTINA M | 1675 | Non-Final OA | Jul 12, 2023 |
| 18327110 | ENGINEERED CELLS AND METHODS OF USE | The Scripps Research Institute | KELLY, ROBERT M | 1638 | Non-Final OA | Jun 01, 2023 |
| 18174015 | Genotypic and Phenotypic Analysis of Circulating Tumor Cells to Monitor Tumor Evolution in Prostate Cancer Patients | The Scripps Research Institute | CANELLA, KAREN A | 1643 | Final Rejection | Feb 24, 2023 |
| 18002611 | SARS-COV-2 RBD CONSTRUCTS | The Scripps Research Institute | HILL, MYRON G | 1671 | Non-Final OA | Dec 20, 2022 |
| 18056554 | PEPTIDIC CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF | The Scripps Research Institute | SANG, HONG | 1646 | Non-Final OA | Nov 17, 2022 |
| 17716848 | COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES | The Scripps Research Institute | SHIN, DANA H | 1635 | Non-Final OA | Apr 08, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial